MRI contrast agent developer Advanced Magnetics of Cambridge,MA, reported last week that it has received a $5 million milestonepayment from Berlex Laboratories due to Berlex's launch of FeridexIV, a liver-specific contrast agent developed by Advanced
MRI contrast agent developer Advanced Magnetics of Cambridge,
MA, reported last week that it has received a $5 million milestone
payment from Berlex Laboratories due to Berlex's launch of Feridex
IV, a liver-specific contrast agent developed by Advanced Magnetics
(SCAN 9/11/96).
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.